Nutratopic Pro-AMP Extended control for atopic skin
Relieves itchiness, prevents scratching and breaks the vicious cycle
Estás a punto de abandonar la web de ISDIN para ir a un espacio privado para profesionales de la salud. ¿Quieres continuar?
Relieves itchiness, prevents scratching and breaks the vicious cycle
Body cream for proactive protection of the specific areas that are usually affected: folds, the areas where the arms and legs bend, chest and neck. It relieves itching, restores the skin barrier and activates the skin’s first line of defense. With a texture that provides immediate comfort, protection and deep moisturisation, strengthening the lipid mantle.
Did you know that intensive, daily, continued care is required to prevent new outbreaks in the injured areas of atopic skin?
In injured areas there is subclinical inflammation even in periods of remission.
Applied twice a day as a coadjuvant in the control of atopy symptoms and as maintenance in periods of remission, Nutratropic PRO-AMP Emollient Lotion improves and prevents the signs associated with atopic dermatitis (itching, reddening, scaling, reactivity and dryness) that course with the inflammatory circle.
With a creamy texture for specific areas, it ensures maximum absorption and effectiveness. With proven efficacy and tolerance. Does not contain preservatives, perfumes or colorants.
In the specific areas in which outbreaks usually appear, NUTRATROPIC PRO-AMP Emollient Lotion effectively combats all the signs of atopic dermatitis, breaking the vicious circle.
The PRO-AMP effect, with its double active protection, strengthens the lipid mantle of the skin and restores the skin barrier, helping to keep atopy under control for longer.
Nutratopic Pro-AMP emollient cream for specific areas reduces the ESS in 67% in 3 weeks and 74% in 6 weeks.
The Eczema Severity Score ESS measures the severity of the lesions in terms of erythema, thickness, itchiness and lichenification of the skin. Evaluation: 0 (non-existent) to severe (3) done in neck, arms and legs.
Study charactersitics: N=15, average age 6 y.o. s. *Agostinis and Milani, EADV 2015, Poster P0212